Protection against recurrent stroke with resveratrol: endothelial protection. - Wikidata - wikimedia - TriplyDB

Protection against recurrent stroke with resveratrol: endothelial protection.

Protection against recurrent stroke with resveratrol: endothelial protection.

http://www.wikidata.org/entity/Q34452311

about

Resveratrol and Cardiovascular Diseases Phytochemical Compounds and Protection from Cardiovascular Diseases: A State of the Art Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular Diseases Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system Mitochondrial function in hypoxic ischemic injury and influence of aging Epsilon PKC increases brain mitochondrial SIRT1 protein levels via heat shock protein 90 following ischemic preconditioning in rats.Interleukin-1 and acute brain injury.Development of a lozenge for oral transmucosal delivery of trans-resveratrol in humans: proof of concept Blood brain barrier and neuroinflammation are critical targets of IGF-1-mediated neuroprotection in stroke for middle-aged female rats.Recurrent mild cerebral ischemia: enhanced brain injury following acute compared to subacute recurrence in the rat Exogenous S1P Exposure Potentiates Ischemic Stroke Damage That Is Reduced Possibly by Inhibiting S1P Receptor Signaling.Resveratrol protects the brain of obese mice from oxidative damage.Multiplex immunoassay characterization and species comparison of inflammation in acute and non-acute ischemic infarcts in human and mouse brain tissue.Resveratrol alleviate hypoxic pulmonary hypertension via anti-inflammation and anti-oxidant pathways in rats.Neuroprotective effects of resveratrol in Alzheimer disease pathology.Natural polyphenols based new therapeutic avenues for advanced biomedical applications.Role of dietary phenols in mitigating microglia-mediated neuroinflammation.Intrahippocampal Administration of Ibotenic Acid Induced Cholinergic Dysfunction via NR2A/NR2B Expression: Implications of Resveratrol against Alzheimer Disease Pathophysiology Resveratrol improves delayed r-tPA treatment outcome by reducing MMPs.[Stroke - lifestyle and environment].Evaluation of Oxidative Stress in Cardiomyocytes during the Aging Process in Rats Treated with Resveratrol.

P2860

Q26752801-86364826-5034-4CB9-9CD4-6AB97578BABA Q26778562-A8BBB3D6-A4CE-4823-8CAA-11E3F44C2622 Q26824390-73C37867-B112-4B3C-B6C5-1E7C56EE7659 Q28073279-06EEC12C-FE87-4866-9EB6-40711B2B6E3D Q28389419-F56A7AE5-1D13-4596-BACE-0FD2214C49E9 Q28396663-389757A4-5638-46F4-8962-C99B971869F4 Q34995143-E6F07C63-65D2-43B6-9FC8-DCEAFE1C42BA Q35056860-EE7CBBBA-1110-49FE-AA58-E3311E1EF472 Q35108724-6E8AA2F5-37E5-4A6E-BC0B-247FD111E565 Q35117479-3E8F8110-C595-498E-B2AF-27B7A9360194 Q36031521-BEFD4971-39E5-4BD2-88B9-52B0679860A9 Q36241484-5E845B31-298A-4281-BADC-B695644005B3 Q37218682-28F3D303-8464-45B8-B824-46EB7F095E16 Q37233361-118D5211-5E1D-43E5-995A-6CEE788100E4 Q37513453-23CD34C9-B46C-463E-BA82-55E45B962ED6 Q38259550-69798576-0878-4D5C-80BB-49ACE02CE74A Q38622865-449B0D52-2D4A-44C7-9CE6-E901715F7C75 Q38910432-AE40FA8F-ECAB-43A3-9F75-580775584E67 Q40622685-9BB1B269-010F-4354-B536-AFB3A055BEA5 Q52148119-6417D6ED-8A9A-4685-8FEF-48826189FEE9 Q52865099-9959BC32-6DB2-4019-B08D-69AA5FE7C906 Q55004338-87D5866E-6138-483E-BDB0-42090A7B0AA1

P2860

Protection against recurrent stroke with resveratrol: endothelial protection.

http://www.wikidata.org/entity/Q34452311

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Protection against recurrent stroke with resveratrol: endothelial protection.

@ast

Protection against recurrent stroke with resveratrol: endothelial protection.

@en

Protection against recurrent stroke with resveratrol: endothelial protection.

@nl

type

label

Protection against recurrent stroke with resveratrol: endothelial protection.

@ast

Protection against recurrent stroke with resveratrol: endothelial protection.

@en

Protection against recurrent stroke with resveratrol: endothelial protection.

@nl

prefLabel

Protection against recurrent stroke with resveratrol: endothelial protection.

@ast

Protection against recurrent stroke with resveratrol: endothelial protection.

@en

Protection against recurrent stroke with resveratrol: endothelial protection.

@nl

P1433

Q34452311-7D9D1F00-30C9-46FC-9B83-AA0249D47E1C

P1476

Q34452311-5F9C8205-40AF-414E-87C4-DF39E1F00589

P2093

Q34452311-0EF74DF2-1270-4BB7-95C6-C8680AA47584

Q34452311-6CE678D6-3FD4-4D8C-B9E3-264ABC1B63BA

Q34452311-79F85181-50F9-4E86-BC75-083025F88455

Q34452311-956B53F8-67B8-4D1E-98C6-D4A058E7ECC4

Q34452311-B0EA0E17-B0F1-4685-BCC7-4ABB300A0DD1

Q34452311-BB4D3F18-CAA9-4703-95DB-82A81BB77707

Q34452311-C02408A3-438A-48B4-87E8-A6C0ECB51D31

Q34452311-CF417BD5-6036-4F44-AE5C-80BDC588F10C

Q34452311-F14648AD-C37E-4BE3-85B7-555F36B11CB7

Q34452311-F79CDE74-7C94-47FB-AB0A-748D337D4430

P2860

Q34452311-0398D205-088F-4E3D-96E2-FD744C8F1C30

Q34452311-0F12DA76-13ED-4EA6-A374-73C6E3C9B811

Q34452311-110FAB40-E19A-447D-85E8-16551329FEA9

Q34452311-11C7767A-8350-41D5-9D0B-D52E2182B68C

Q34452311-2942F17D-2DCF-4E77-AC61-187D22537FA0

Q34452311-3308465C-17A5-446D-BF06-31AFB7AA844E

Q34452311-3FE2184A-ADC5-40DA-9E57-FAC70637E785

Q34452311-48B7777A-1D10-4EFB-8D3C-326698D22747

Q34452311-50025082-7EE6-4619-AED6-FBD131C37D95

Q34452311-55D0DCB6-1099-45DF-8AB1-6E42ED6EC1BE

P304

Q34452311-F7511403-881B-4E70-9175-8C2D06BE4C54

P31

Q34452311-E1DBF502-CC34-49B0-87DE-A24C18969291

P356

Q34452311-0D3BD69A-1EB1-41DE-9A3E-779BDBAD688F

P407

Q34452311-68CEE01E-3151-4AC8-A2CA-D3357C0F0BC9

P433

Q34452311-7D9E71D8-8214-43C9-9AFD-23A062D5F1DE

P478

Q34452311-6DF9AB20-3A30-4615-AF28-3537F72DA731

P577

Q34452311-AE38B3F2-E5E7-48CA-A6A1-4D5E9499C857

P5875

Q34452311-330ACAB9-C93D-4F4A-960A-6525A17ECC65

P698

Q34452311-7E4AA142-F97E-41E4-830C-A7D4541BFDF1

P921

Q34452311-13F57F65-8DCC-4121-9D28-01C87ACC724F

P932

Q34452311-5EEA6B3C-BC55-42FC-867F-F55EBF1EC9B1

P356

JOURNAL.PONE.0047792

P1433

P1476

Protection against recurrent stroke with resveratrol: endothelial protection.

@en

P2093

Adam Institoris

http://www.w3.org/2001/XMLSchema#string

Angela Kulynych

http://www.w3.org/2001/XMLSchema#string

Darren Clark

http://www.w3.org/2001/XMLSchema#string

David W Busija

http://www.w3.org/2001/XMLSchema#string

David W Kinniburgh

http://www.w3.org/2001/XMLSchema#string

Ferenc Bari

http://www.w3.org/2001/XMLSchema#string

Philip A Barber

http://www.w3.org/2001/XMLSchema#string

Roger Thompson

http://www.w3.org/2001/XMLSchema#string

Ursula I Tuor

http://www.w3.org/2001/XMLSchema#string

Xu Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Blood-brain barrier breakdown in acute and chronic cerebrovascular disease

Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway

Therapeutic potential of resveratrol: the in vivo evidence

Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity.

Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2.

Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats.

Resveratrol attenuates oxidized LDL-evoked Lox-1 signaling and consequently protects against apoptotic insults to cerebrovascular endothelial cells.

Pathways for ischemic cytoprotection: role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning.

Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly.

The neurovascular unit, matrix proteases, and innate inflammation.

P304

e47792

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0047792

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232321493

http://www.w3.org/2001/XMLSchema#string

P698

23082218

http://www.w3.org/2001/XMLSchema#string

P921

P932

3474795

http://www.w3.org/2001/XMLSchema#string